Tomoyuki Aruga

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés, David W. Cescon, Hope S. Rugo et al. · The Lancet · 2020 · 1.8K citations · Full text

Medicine, Oncology, Pharmacology +16

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson et al. · The Lancet Oncology · 2017 · 122 citations

Medicine, Gynecology, Oncology +13

Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM)

Naoki Niikura, Takashi Yamanaka, Hironori Nomura et al. · npj Breast Cancer · 2023 · 67 citations · Full text

Medicine, Oncology, Pharmacology +17

Decreased expression of SOCS-3 mRNA in breast cancer with lymph node metastasis

Tsuyoshi Nakagawa, Satoru Iida, Takayuki Osanai et al. · Oncology Reports · 2008 · 41 citations · Full text

Medicine, Molecular Biology, Oncology +15

Tumor development in Japanese patients with Lynch syndrome

Chiaki Saita, Tatsuro Yamaguchi, Shinichiro Horiguchi et al. · PLoS ONE · 2018 · 36 citations · Full text

Medicine, Oncology, Pathology +17